About Contact Us Careers

Dermatophytosis Treatment Market - Top Companies and Manufacturers

Request Free Sample Copy

Report ID: 3631
Published Date: Dec 24, 2024
Report Format: PDF, PPT

Buy Now

Companies Dominating the Dermatophytosis Treatment Landscape

Galderma S.A.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Novartis AG
Pfizer, Inc.
Moberg Pharma AB
Janssen Global Services, LLC
Valeant Pharmaceuticals International Inc.
Anacor Pharmaceuticals, Inc.
NovaQuest Capital Management, L.L.C.
Novan, Inc
Valeant Pharmaceuticals International Inc.

Browse Key Market Insights with Data Illustration:

Dermatophytosis Treatment Market Size & Share, Growth Report 2037

In the News

April 2021- Galderma announced the publication of phase 2b trial results demonstrating the long-lasting and rapid benefits of nemolizumab.

Author Credits: Radhika Pawar

Report ID: 3631
Published Date: Dec 24, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of dermatophytosis treatment is estimated at USD 9.65 billion.

Dermatophytosis Treatment Market size was valued at USD 9.27 billion in 2024 and is likely to cross USD 17.05 billion by 2037, expanding at more than 4.8% CAGR during the forecast period i.e., between 2025-2037.

Asia Pacific industry is poised to hold largest revenue share by 2037, propelled by increasing geriatric population, and significant improvements in the healthcare facility in the region.

The major players in the market are Galderma S.A., Novartis AG, Pfizer, Inc., Moberg Pharma AB, Janssen Global Services, LLC, and others.

Inquiry Before Buying Request Free Sample